US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 14.390
  • +0.190+1.34%
Close Nov 29 13:00 ET
  • 14.920
  • +0.530+3.68%
Post 17:01 ET
1.31BMarket Cap-5271P/E (TTM)

Rocket Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rocket Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 34.780K--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 34.780K--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Rocket Pharmaceuticals Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 7 16:54 ET

  • 8-K: Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

    Nov 7 16:29 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 6 16:37 ET

  • 8-K: Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

    Aug 5 16:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      92.31%

    • Hold

      7.69%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data